← Back to Search

People at risk of PAD for Peripheral Arterial Disease

N/A
Recruiting
Research Sponsored by Kent Imaging Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-2 days
Awards & highlights

Study Summary

The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can accurately evaluate the degree of Peripheral Arterial Disease (PAD) during a Provocative Elevation Maneuver of the Lower Extremity (PEMLE) test, as compared to routine clinical assessments.

Eligible Conditions
  • Peripheral Arterial Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-2 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-2 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparing change in plantar foot NIRS measurements (baseline vs raised position) during a Provocative Maneuver Leg Raise test to the SOC clinical assessment of PAD
Secondary outcome measures
Change of NIRS measurements with other positions
Comparing change in dorsal foot NIRS measurements (baseline vs raised position) during a Provocative Maneuver Leg Raise test to the SOC clinical assessment of PAD
Comparing change in plantar foot NIRS measurements (baseline vs raised position) during a Provocative Maneuver Leg Raise test paired with the presence/absence of diabetes to the SOC clinical assessment of PAD

Trial Design

1Treatment groups
Experimental Treatment
Group I: People at risk of PADExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Kent Imaging IncLead Sponsor
The University of Texas Health Science Center at San AntonioOTHER
452 Previous Clinical Trials
91,264 Total Patients Enrolled
3 Trials studying Peripheral Arterial Disease
48 Patients Enrolled for Peripheral Arterial Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~95 spots leftby Dec 2024